Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Calcium Channel Blockers/administration & dosage"'
Autor:
Uwe Tegtbur, Rudi Stinkens, Thomas Langenickel, Gijs H. Goossens, Jens Jordan, Tim Heise, Marcus May, Stefan Engeli, Bas Havekes, Sven Haufe, Ellen E. Blaak, Thomas Jax, Diego Albrecht, Parasar Pal
Publikováno v:
Hypertension (Dallas, Tex. : 1979)
Hypertension, 71(1), 70-77. LIPPINCOTT WILLIAMS & WILKINS
Hypertension, 71(1), 70-77. LIPPINCOTT WILLIAMS & WILKINS
Supplemental Digital Content is available in the text.
Sacubitril/valsartan (LCZ696), a novel angiotensin receptor-neprilysin inhibitor, was recently approved for the treatment of heart failure with reduced ejection fraction. Neprilysin degrades
Sacubitril/valsartan (LCZ696), a novel angiotensin receptor-neprilysin inhibitor, was recently approved for the treatment of heart failure with reduced ejection fraction. Neprilysin degrades
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf17af867ef9d1760870ae64e6058500
https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.117.10224
https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.117.10224
Publikováno v:
Acta Neurochirurgica. 151:595-599
BACKGROUND: Cerebral vasospasm triggered by subarachnoid haemorrhage is one of the major causes of post-haemorrhage morbidity and mortality. Several treatment modalities have been proposed, and none of them are fully effective. METHODS: In this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3fd935040d232b8bd561fd1645c18f
https://doi.org/10.1007/s00701-009-0295-4
https://doi.org/10.1007/s00701-009-0295-4
Publikováno v:
American Journal of Hypertension. 11(9):1074-1079
Double-blind, randomized controlled studies of longer than 1 week in duration comparing the antiproteinuric potential of long-acting dihydropyridine calcium channel blockers with that of angiotensin converting enzyme (ACE) inhibitors are lacking. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::218a5ce467f5e8b8a0e0a6c359425c0b
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4
Publikováno v:
American Journal of Hypertension, 11(9), 1074-1079. Oxford Univ. Press, New York
Double-blind, randomized controlled studies of longer than 1 week in duration comparing the antiproteinuric potential of long-acting dihydropyridine calcium channel blockers with that of angiotensin converting enzyme (ACE) inhibitors are lacking. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::70ca8ee0d58f12bdfbfab8d6403952e6
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4
Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia
PubMed ID: 9726620
Objective: Neurological injury due to transient cerebral ischemia is a potential complication of cardiovascular surgery. The neuroprotective effect of magnesium, when given subcutaneously before the ischemia, was assessed in a
Objective: Neurological injury due to transient cerebral ischemia is a potential complication of cardiovascular surgery. The neuroprotective effect of magnesium, when given subcutaneously before the ischemia, was assessed in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dd01268fcb1d9d6ed22814374d57f987
https://hdl.handle.net/11454/23624
https://hdl.handle.net/11454/23624
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.